logo
  • Kontakt
  • ENG
  • EE
  • Kontakt
  • ENG
  • EE
Avaleht Resources

Resources

    • MAI 29, 2025

    TBD Pharmatech at CPHI Europe 2025 – Frankfurt

    We’re excited to announce that TBD Pharmatech will be attending CPHI Europe 2025! 📅 When: 28 – 30 October 2025📍 Where: Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany🔗…

    Read more
    • haldur
    • Events
    • MAI 29, 2025

    TBD Pharmatech at Nordic Life Science Days 2025 – Gothenburg

    We’re excited to announce that TBD Pharmatech will be attending Nordic Life Science Days 2025! 📅 When: 13–14 October 2025📍 Where: Svenska Mässan, Mässans Gata/Korsvägen, 412 94 Göteborg,…

    Read more
    • haldur
    • Events
    • MAI 14, 2025

    TBD Pharmatech at BayOConnect 2025 – Munich

    We’re excited to announce that TBD Pharmatech will be attending BayOConnect 2025! 📅 When: 1 – 2 July 2025, 09:00 – 18:00 CEST📍 Where: Design Offices München Macherei (M6), Weihenstephaner…

    Read more
    • haldur
    • Events
    • APRILL 24, 2025

    TDB Pharmatech at Chemspec Europe 2025 – Cologne

    We’re excited to announce that TBD Pharmatech will be attending Chemspec Europe 2025! Come meet our team to discuss your fine & specialty chemicals projects, explore partnership opportunities,…

    Read more
    • haldur
    • Events
    • JAANUAR 17, 2025

    Project: Small-molecule Novel Drug Ingredients Lab (RE.5.04.23-0268) – Preparative Flash Chromatography with an ELSD marks

    TBD Pharmatech’s recent addition of Preparative Flash Chromatography with an ELSD marks a significant enhancement in our “Small-molecule Novel Drug Ingredients Lab” project. This sophisticated…

    Read more
    • haldur
    • Science
    • AUGUST 28, 2024

    Project: Small-molecule Novel Drug Ingredients Lab (RE.5.04.23-0268) – 150L Jacketed Glass Reactor

    TBD Pharmatech’s recent procurement of 150L Jacketed glass reactor with thermostat, as part of the “Small-molecule Novel Drug Ingredients Lab” project, will add new capabilities to our organic…

    Read more
    • haldur
    • Science
  • 1
  • 2
  • 3
  • ›
  • »

Categories

  • Rubriike pole

Archives

  • mai 2025
  • aprill 2025
  • jaanuar 2025
  • august 2024
  • aprill 2024
  • veebruar 2024
  • jaanuar 2024
  • november 2023
  • september 2023
  • august 2023
  • juuli 2023
  • mai 2023
  • aprill 2023
  • märts 2023
  • veebruar 2023
  • jaanuar 2023
  • detsember 2022
  • november 2022
  • oktoober 2022
  • september 2022
    Ravimainete arendaja ja tootja, mis pakub peenkeemia lahendusi farmaatsia- ja biotehnoloogia ettevõttetele.

    Menu

    • Kontakt
    • ENG
    • EE

    Kontakt

    TBD Pharmatech at CPHI…

    mai 29, 2025

    TBD Pharmatech at Nordic…

    mai 29, 2025

    TBD Pharmatech at BayOConnect…

    mai 14, 2025

    TDB Pharmatech at Chemspec…

    aprill 24, 2025

    Project: Small-molecule Novel Drug…

    jaanuar 17, 2025

    Project: Small-molecule Novel Drug…

    august 28, 2024

    TBD Pharmatech Production Building…

    aprill 8, 2024

    TBD Pharmatech at European…

    veebruar 27, 2024

    TBD Pharmatech team accepted…

    jaanuar 24, 2024

    Project: Small-molecule Novel Drug…

    jaanuar 24, 2024

    GMP API Development Process…

    jaanuar 16, 2024

    TBD attended CPHI Barcelona…

    november 10, 2023

© 2023 TBD Pharmatech OÜ. All rights reservedPrivacy policyTerms and conditionsPowered by Häk
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}